Literature DB >> 16896595

Intensity-modulated radiation therapy (IMRT) with different combinations of treatment-planning systems and linacs: issues and how to detect them.

Barbara Dobler1, Friedlieb Lorenz, Hansjörg Wertz, Martin Polednik, Dirk Wolff, Volker Steil, Frank Lohr, Frederik Wenz.   

Abstract

PURPOSE: To compare different combinations of intensity-modulated radiation therapy (IMRT) system components with regard to quality assurance (QA), especially robustness against malfunctions and dosimetry.
MATERIAL AND METHODS: Three different treatment-planning systems (TPS), two types of linacs and three multileaf collimator (MLC) types were compared: commissioning procedures were performed for the combination of the TPS Corvus 5.0 (Nomos) and KonRad v2.1.3 (Siemens OCS) with the linacs KD2 (Siemens) and Synergy (Elekta). For PrecisePLAN 2.03 (Elekta) measurements were performed for Elekta Synergy only. As record and verify (R&V) system Multi-Access v7 (IMPAC) was used. The use of the serial tomotherapy system Peacock (Nomos) was investigated in combination with the Siemens KD2 linac.
RESULTS: In the comparison of calculated to measured dose, problems were encountered for the combination of KonRad and Elekta MLC as well as for the Peacock system. Multi-Access failed to assign the collimator angle correctly for plans with multiple collimator angles per beam. Communication problems of Multi-Access with both linacs were observed, resulting in incorrect recording of the treatment. All reported issues were addressed by the manufacturers.
CONCLUSION: For the commissioning of IMRT systems, the whole chain from the TPS to the linac has to be investigated. Components that passed the commissioning in another clinical environment can have severe malfunctions when used in a new environment. Therefore, not only single components but the whole chain from planning to delivery has to be evaluated in commissioning and checked regularly for QA.

Entities:  

Mesh:

Year:  2006        PMID: 16896595     DOI: 10.1007/s00066-006-1544-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  9 in total

1.  Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO++.

Authors:  Dirk Wolff; Florian Stieler; Brigitte Hermann; Katharina Heim; Sven Clausen; Jens Fleckenstein; Martin Polednik; Volker Steil; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

2.  Quasi-IMAT study with conventional equipment to show high plan quality with a single gantry arc.

Authors:  Judith Alvarez Moret; Oliver Kölbl; Ludwig Bogner
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

3.  [Department and patient management in radiotherapy. The Freiburg model].

Authors:  Felix Heinemann; Fred Röhner; Marianne Schmucker; Gregor Bruggmoser; Karl Henne; Anca-Ligia Grosu; Hermann Frommhold
Journal:  Strahlenther Onkol       Date:  2009-03-28       Impact factor: 3.621

4.  Curcumin decreases survival of Hep3B liver and MCF-7 breast cancer cells: the role of HIF.

Authors:  Mareike Ströfer; Wolfgang Jelkmann; Reinhard Depping
Journal:  Strahlenther Onkol       Date:  2011-06-27       Impact factor: 3.621

5.  MRI assessment of cervical cancer for adaptive radiotherapy.

Authors:  Johannes C A Dimopoulos; Gertrude Schirl; Anja Baldinger; Thomas H Helbich; Richard Pötter
Journal:  Strahlenther Onkol       Date:  2009-05-15       Impact factor: 3.621

6.  Monitoring of tumor oxygenation changes in head-and-neck carcinoma patients breathing a hyperoxic hypercapnic gas mixture with a noninvasive MRI technique.

Authors:  Markus Kotas; Peter Schmitt; Peter M Jakob; Michael Flentje
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

7.  [First results of the federal quality assurance group ("Arztliche Stelle") in radiotherapy in baden-württemberg: part 1].

Authors:  Hans Hawighorst; Gerd Becker; Norbert Hodapp; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

8.  A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT).

Authors:  Florian Stieler; Dirk Wolff; Frank Lohr; Volker Steil; Yasser Abo-Madyan; Friedlieb Lorenz; Frederik Wenz; Sabine Mai
Journal:  Radiat Oncol       Date:  2009-10-25       Impact factor: 3.481

9.  Influence of different treatment techniques on radiation dose to the LAD coronary artery.

Authors:  Carsten Nieder; Sabine Schill; Peter Kneschaurek; Michael Molls
Journal:  Radiat Oncol       Date:  2007-06-05       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.